Guardant Health, Inc. (GH) Financial Statements

Executive TeamFinancials
SegmentsShareholders

Guardant Health financial statements at a glance

Guardant Health reported revenue of $982.02 million for fiscal year 2025 (ended December 31, 2025), up 32.9% from fiscal year 2024. Net income was -$416.28 million, a net margin of 42.4% loss, and diluted earnings per share were -$3.32.

At the end of fiscal year 2025 it had total assets of $2.01 billion, total liabilities of $2.11 billion and shareholders' equity of -$99.31 million, with cash and short-term investments of $1.20 billion and total debt of $1.71 billion.

Its operations brought in -$184.76 million of cash; capital spending was $48.31 million, leaving free cash flow of -$233.07 million.

The tables below show the income statement, balance sheet and cash flow statement; the key figures of the last 5 fiscal years are at the bottom of the page.

Figures from company filings, in USD; latest fiscal year ended December 31, 2025.

GH logo

Guardant Health, Inc.

GHUnited States
Healthcare
USD (Local)

Income Statement

Annual • USD

Total Revenue
982.02M
Prev Year: 739.02M
YoY: +32.9%
Operating Revenue
982.02M
Prev Year: 739.02M
YoY: +32.9%
Net Income from Continuing Operation Net Minority Interest
-416.28M
Prev Year: -436.37M
YoY: +4.6%
Normalized EBITDA
-373.91M
Prev Year: -390.12M
YoY: +4.2%
Total Unusual Items Excluding Goodwill
-
Tax Rate for Calcs
0.003
Prev Year: 0
Total Unusual Items
-
Selling and Marketing Expense
494.66M
Prev Year: 364.94M
YoY: +35.5%
General and Administrative Expense
211.41M
Prev Year: 180.12M
YoY: +17.4%
Other General and Administrative
211.41M
Prev Year: 180.12M
YoY: +17.4%
Cost of Revenue
349.01M
Prev Year: 289.80M
YoY: +20.4%
Gross Profit
633.01M
Prev Year: 449.22M
YoY: +40.9%
Operating Expense
1.07B
Prev Year: 892.81M
YoY: +19.9%
Selling General and Administrative
706.07M
Prev Year: 545.06M
YoY: +29.5%
Research and Development
364.19M
Prev Year: 347.75M
YoY: +4.7%
Operating Income
-437.25M
Prev Year: -443.59M
YoY: +1.4%
Net Non Operating Interest Income Expense
30.20M
Prev Year: 51.11M
YoY: -40.9%
Non-operating Interest Income
34.09M
Prev Year: 53.69M
YoY: -36.5%
Non-operating Interest Expense
3.90M
Prev Year: 2.58M
YoY: +51.0%
Other Income Expense
-10.49M
Prev Year: -42.60M
YoY: +75.4%
Other Non-operating Income (expense)
-10.49M
Prev Year: -42.60M
YoY: +75.4%
Special Income Charges
-
Pre-tax Income
-417.54M
Prev Year: -435.09M
YoY: +4.0%
Provision for Income Taxes
-1.26M
Prev Year: 1.28M
YoY: -198.4%
Net Income Common Stockholders
-416.28M
Prev Year: -436.37M
YoY: +4.6%
Net Income
-416.28M
Prev Year: -436.37M
YoY: +4.6%
Net Income Including Non-Controlling Interests
-416.28M
Prev Year: -436.37M
YoY: +4.6%
Net Income from Continuing Operations
-416.28M
Prev Year: -436.37M
YoY: +4.6%
Diluted NI Available to Com Stockholders
-416.28M
Prev Year: -436.37M
YoY: +4.6%
Basic EPS
-3.32
Prev Year: -3.56
YoY: +6.7%
Diluted EPS
-3.32
Prev Year: -3.56
YoY: +6.7%
Weighted Average Shares (basic)
125.37M
Prev Year: 122.75M
YoY: +2.1%
Weighted Average Shares (diluted)
125.37M
Prev Year: 122.75M
YoY: +2.1%
Total Operating Income as Reported
-437.25M
Prev Year: -443.59M
YoY: +1.4%
Total Expenses
1.42B
Prev Year: 1.18B
YoY: +20.0%
Net Income from Continuing and Discontinued Operation
-416.28M
Prev Year: -436.37M
YoY: +4.6%
Normalized Income
-416.28M
Prev Year: -436.37M
YoY: +4.6%
Interest Income
34.09M
Prev Year: 53.69M
YoY: -36.5%
Interest Expense
3.90M
Prev Year: 2.58M
YoY: +51.0%
Net Interest Income
30.20M
Prev Year: 51.11M
YoY: -40.9%
EBIT
-413.64M
Prev Year: -432.51M
YoY: +4.4%
EBITDA
-373.91M
Prev Year: -390.12M
YoY: +4.2%
Reconciled Cost of Revenue
349.01M
Prev Year: 289.80M
YoY: +20.4%
Reconciled Depreciation
39.74M
Prev Year: 42.39M
YoY: -6.3%
Values in USD

Guardant Health key figures by fiscal year

FY2025FY2024FY2023FY2022FY2021
Revenue$982.0M$739.0M$563.9M$449.5M$373.7M
Gross profit$633.0M$449.2M$336.9M$293.2M$250.7M
Operating income-$437.2M-$443.6M-$564.7M-$544.4M-$411.0M
Net income-$416.3M-$436.4M-$479.4M-$654.6M-$405.7M
Diluted EPS-$3.32-$3.56-$4.28-$6.41-$4.00
Total assets$2.0B$1.5B$1.8B$1.6B$2.2B
Total liabilities$2.1B$1.6B$1.6B$1.5B$1.6B
Shareholders' equity-$99.3M-$139.6M$158.7M$60.2M$645.0M
Cash and short-term investments$1.2B$840.0M$1.2B$1.0B$932.7M
Total debt$1.7B$1.3B$1.4B$1.4B$1.4B
Operating cash flow-$184.8M-$239.9M-$325.0M-$309.5M-$209.0M
Capital spending$48.3M$35.1M$20.5M$77.5M$75.0M
Free cash flow-$233.1M-$274.9M-$345.5M-$386.9M-$284.1M

In USD. Fiscal years as reported by the company; statements on this page go back to fiscal year 2016.

Questions and answers

What was Guardant Health's revenue in fiscal year 2025?

$982.02 million, up 32.9% from $739.02 million in fiscal year 2024.

How much profit does Guardant Health make?

Guardant Health reported net income of -$416.28 million for fiscal year 2025 (42.4% of revenue); operating income was -$437.25 million.

How much cash and debt does Guardant Health have?

At the end of fiscal year 2025: cash and short-term investments of $1.20 billion and total debt of $1.71 billion.

What is Guardant Health's free cash flow?

-$233.07 million in fiscal year 2025 (operating cash flow of -$184.76 million minus capital spending of $48.31 million).

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube